First-trimester maternal factors and biomarker screening for preeclampsia: Asia-wide study

First-trimester maternal factors and biomarker screening for preeclampsia: Asia-wide study - Asia-wide study for preeclampsia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030347

Enrollment

2000

Registered

2017-12-11

Start date

2017-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclamsia

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Singleton pregnancy, 11+0 to 13+6 weeks of gestation

Exclusion criteria

Exclusion criteria: Large fetal anomaly, multiple pregnancy, intrauterine fetal death

Design outcomes

Primary

Measure	Time frame
Uterine artery pulsatility index (UtAPI), maternal serum placental growth factor (PlGF)	—

Secondary

Measure	Time frame
Mean arterial blood pressure (MAP), medical and obsteric history	—

Countries

Japan

Contacts

Public ContactArihiro Shiozaki

Toyama University Hospital Obstetrics and Gynecology

s33shio@med.u-toyama.ac.jp076-434-7357

Outcome results